(Q37651897)

21 August 2017

1 reference

title

Stem cell therapy in acute myocardial infarction: a review of clinical trials (English)

1 reference

acute myocardial infarction

21 August 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

Jon C George

1

1 reference

21 August 2017

1 January 2010

1 reference

21 August 2017

Translational Research

1 reference

21 August 2017

155

1 reference

21 August 2017

1

1 reference

21 August 2017

10-19

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

21 August 2017

1 reference

Isolation of putative progenitor endothelial cells for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Methods of stem cell delivery in cardiac diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimul

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Granulocyte colony stimulating factor in patients with large acute myocardial infarction: Results of a pilot dose-escalation randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Usefulness of Granulocyte Colony-Stimulating Factor in Patients With a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling (The Rigenera Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Bone marrow cells adopt the cardiomyogenic fate in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

How to trace stem cells for MRI evaluation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.06.009

10.1016/J.TRSL.2009.06.009

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

20004357